Preclinical Models in Mesothelioma

Published: Jan 1, 2019
Abstract
Malignant mesothelioma is a rare and aggressive cancer with a poor prognosis. Clinical studies are challenging, so preclinical models are needed to improve our knowledge of the disease so as to develop new therapeutic options. Different in vitro and in vivo models are available. Primary and immortalized cell lines are useful to study genomic alterations, to identify possible biomarkers, and to screen new drugs, but they do not reproduce the...
Paper Details
Title
Preclinical Models in Mesothelioma
Published Date
Jan 1, 2019
Journal
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.